Home › Research › Biomarkers
Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Esther S Oh, Kaj Blennow, George E Bigelow, Sharon K Inouye, Edward R Marcantonio, Karin J Neufeld, Paul B Rosenberg, Juan C Troncoso et al.. PloS one, 2018-09-25
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Among the hip fracture patients, 88.6% of the cognitively normal (Clinical Dementia Rating-CDR 0; n = 70) and 98.8% with mild cognitive impairment (CDR 0.5; n = 81) fell in the abnormal biomarker categories by the A/T/N classification. A large proportion of older hip fracture patients have CSF evidence of AD pathology. Preoperative determination of AD biomarkers may play a crucial role in identifying persons without dementia who have underlying AD pathology in perioperative settings.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Oh, E. S., Blennow, K., Bigelow, G. E., Inouye, S. K., Marcantonio, E. R., Neufeld, K. J., et al. (2018). Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia. PloS one. https://doi.org/10.1371/journal.pone.0204695
Vancouver
Oh ES, Blennow K, Bigelow GE, Inouye SK, Marcantonio ER, Neufeld KJ, et al. Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia. PloS one. 2018. doi:10.1371/journal.pone.0204695. PMID: 30252906.
BibTeX
@article{oh2018-30252906,
author = {Oh, Esther S and Blennow, Kaj and Bigelow, George E and Inouye, Sharon K and Marcantonio, Edward R and Neufeld, Karin J and Rosenberg, Paul B and Troncoso, Juan C and others},
title = {{Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia}},
journal = {PloS one},
year = {2018},
doi = {10.1371/journal.pone.0204695},
pmid = {30252906},
url = {https://doi.org/10.1371/journal.pone.0204695}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Among the hip fracture patients, 88.6% of the cognitively normal (Clinical Dementia Rating-CDR 0; n = 70) and 98.8% with mild cognitive impairment (CDR 0.5; n = 81) fell in the abnormal biomarker categories by the A/T/N classification.
- A large proportion of older hip fracture patients have CSF evidence of AD pathology.
- Preoperative determination of AD biomarkers may play a crucial role in identifying persons without dementia who have underlying AD pathology in perioperative settings.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants70
- Effect size88.6%; 98.8%
- Evidence strengthLow
How this study scored 50/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 28 of the 56 points we could judge it on, which is 50 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (PloS one) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 70 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30252906) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 28 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 28 of the 56 points we could judge it on is 50 out of 100. |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.